000 | 01136 a2200325 4500 | ||
---|---|---|---|
005 | 20250513202752.0 | ||
264 | 0 | _c20000229 | |
008 | 200002s 0 0 eng d | ||
022 | _a1056-4993 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMadrid, A L | |
245 | 0 | 0 |
_aPharmacologic management of psychiatric and behavioral symptoms in mental retardation. _h[electronic resource] |
260 |
_bChild and adolescent psychiatric clinics of North America _cJan 2000 |
||
300 |
_a225-43, x-xi p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aChild Behavior Disorders _xdiagnosis |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntellectual Disability _xdiagnosis |
650 | 0 | 4 |
_aMental Disorders _xdiagnosis |
650 | 0 | 4 |
_aPsychotropic Drugs _xadverse effects |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aState, M W | |
700 | 1 | _aKing, B H | |
773 | 0 |
_tChild and adolescent psychiatric clinics of North America _gvol. 9 _gno. 1 _gp. 225-43, x-xi |
|
999 |
_c10628581 _d10628581 |